Steen R G, Koury B S M, Granja C I, Xiong X, Wu S, Glass J O, Mulhern R K, Kun L E, Merchant T E
Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA.
Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):79-91. doi: 10.1016/s0360-3016(00)01351-1.
To test a hypothesis that fractionated radiation therapy (RT) to less than 60 Gy is associated with a dose-related change in the spin-lattice relaxation time (T1) of normal brain tissue, and that such changes are detectable by quantitative MRI (qMRI).
Each of 21 patients received a qMRI examination before treatment, and at several time points during and after RT. A map of brain T1 was calculated and segmented into white matter and gray matter at each time point. The RT isodose contours were then superimposed upon the T1 map, and changes in brain tissue T1 were analyzed as a function of radiation dose and time following treatment. We used a mixed-model analysis to analyze the longitudinal trend in brain T1 from the start of RT to 1 year later. Predictive factors evaluated included patient age and clinical variables, such as RT dose, time since treatment, and the use of an imaging contrast agent.
In white matter (WM), a dose level of greater than 20 Gy was associated with a dose-dependent decrease in T1 over time, which became significant about 3 months following treatment. In gray matter (GM), there was no significant change in T1 over time, as a function of RT doses < 60 Gy. However, GM in close proximity to the tumor had an inherently lower T1 before therapy. Neither use of a contrast agent nor a combination of chemotherapy plus steroids had a significant effect on brain T1.
Results suggest that T1 mapping may be sensitive to radiation-related changes in human brain tissue T1. WM T1 appears to be unaffected by RT at doses less than approximately 20 Gy; GM T1 does not change at doses less than 60 Gy. However, tumor appears to have an effect upon adjacent GM, even before treatment. Conformal RT may offer a substantial benefit to the patient, by minimizing the volume of normal brain exposed to greater than 20 Gy.
验证一个假设,即分割放射治疗(RT)剂量小于60 Gy与正常脑组织的自旋晶格弛豫时间(T1)的剂量相关变化有关,并且这种变化可通过定量磁共振成像(qMRI)检测到。
21例患者在治疗前、RT期间及治疗后的几个时间点均接受了qMRI检查。在每个时间点计算脑T1图谱,并将其分割为白质和灰质。然后将RT等剂量线轮廓叠加在T1图谱上,并分析脑组织T1的变化与放射剂量及治疗后时间的关系。我们使用混合模型分析来分析从RT开始到1年后脑T1的纵向趋势。评估的预测因素包括患者年龄和临床变量,如RT剂量、治疗后的时间以及是否使用成像造影剂。
在白质(WM)中,大于20 Gy的剂量水平与T1随时间的剂量依赖性降低相关,这种降低在治疗后约3个月变得显著。在灰质(GM)中,随着RT剂量<60 Gy,T1随时间没有显著变化。然而,靠近肿瘤的GM在治疗前T1固有地较低。使用造影剂或化疗加类固醇的联合使用对脑T1均无显著影响。
结果表明,T1图谱可能对人脑组织T1的辐射相关变化敏感。剂量小于约20 Gy时,WM的T1似乎不受RT影响;剂量小于60 Gy时,GM的T1没有变化。然而,即使在治疗前,肿瘤似乎也对相邻的GM有影响。适形RT通过最小化暴露于大于20 Gy的正常脑体积,可能为患者带来实质性益处。